Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2007;335:267-268 (11 August), doi:10.1136/bmj.39293.453090.AD
Has not improved patient outcomes in the UK
| The first 150 words of the full text of this article appear below. |
Most patients with cancer who are not diagnosed by screening will be diagnosed after symptoms develop, so timely referral of patients to specialists is essential. In this week's BMJ Potter and colleagues assess the long term impact of the "two week wait" rule in the United Kingdom for breast cancer on referral patterns, diagnoses of cancer, and waiting times.1 Their study found that the diagnosis of cancer in people referred within two weeks significantly decreased in the period 1999-2005 (12.8% v 7.7%, P<0.001) and diagnoses in people referred through the routine route increased (2.5% v 5.3%, P<0.001). The study suggests that the current cancer referral policy in the UK—whereby patients with a given set of symptoms are seen within two weeks—results in more patients who have cancer being seen on routine waiting lists than on the fast track list. This means diagnosis is delayed even further. Why is this so,
Moyez Jiwa, professor of primary care1, Christobel Saunders, professor of surgical oncology2
1 WA Centre for Cancer and Palliative Care, Health Research Campus, Curtin University of Technology, GPO Box U1987, Perth, WA 6845, Australia, 2 School of Surgery and Pathology, QEII Medical Centre, Perth, WA 6009
Correspondence to: M Jiwa m.jiwa@curtin.edu.au
Read all Rapid Responses